Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Oct;42(10):2749-51.
doi: 10.1128/AAC.42.10.2749.

Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori

Y J Debets-Ossenkopp  1 , A B Brinkman, E J Kuipers, C M Vandenbroucke-Grauls, J G Kusters
Affiliations

Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori

Y J Debets-Ossenkopp et al. Antimicrob Agents Chemother. 1998 Oct.

Abstract

A single point mutation in the 23S rRNA gene of Helicobacter pylori is known to confer resistance to clarithromycin. Most prevalent among clarithromycin-resistant clinical H. pylori isolates are the mutations from A-2142 to G and A-2143 to G in the 23S rRNA gene. The bias in the 23S rRNA gene mutations conferring clarithromycin resistance may result from the higher MIC, stability of resistance, and growth rate found for the strains with the above-mentioned mutations.

PubMed Disclaimer

References

    1. Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K, editors. Current protocols in molecular biology. New York, N.Y: Greene Publishing Associates and Wiley Interscience; 1989.
    1. Debets-Ossenkopp Y J, Sparrius M, Kusters J G, Kolkman J J, Vandenbroucke-Grauls C M J E. Mechanism of clarithromycin resistance in clinical isolates of H. pylori. FEMS Microbiol Lett. 1996;142:37–42. - PubMed
    1. The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut. 1997;41:8–13. - PMC - PubMed
    1. Hultén K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother. 1997;41:2550–2553. - PMC - PubMed
    1. Marshall B J, Warren J R, Blincow E D, Philips M, Goodwin C S, Murray R, Blackbourn S J, Waters T E, Sanderson C R. Prospective double-blind trial of duodenal relapse after eradication of Campylobacter pylori. Lancet. 1988;ii:1437–1441. - PubMed

Publication types

MeSH terms